Kristina Yu. Permyakova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kristina Yu. Permyakova has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Alexander V. Ivanov
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia
4 shared publications - Alla A. Kushch
Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia
4 shared publications - Ekaterina I. Lesnova
Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia
4 shared publications - Nikolai Vasilyevich Pimenov
Moscow state Academy of Veterinary Medicine and Biotechnology – MVA by K.I. Skryabin
4 shared publications - Olga V. Masalova
Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia
4 shared publications - Saida N. Marzanova
K.I. Skhryabin Moscow State Academy of Veterinary Medicine and Biotechnology – MVA by K.I. Skryabin
4 shared publications
Latest Publications
- Open Access
Immunogenicity of a Candidate Hepatitis C Vaccine Based on Non-Structural DNA-Protein Sequences and a Novel Complex Adjuvant
Global elimination of hepatitis C virus (HCV) infection requires not only direct-acting antivirals (DAAs) but also the development of a highly effective prophylactic and/or therapeutic vaccine. Background/Objectives: Our aim was to optimize the composition of the candidate vaccine against HCV by combining recombinant non-structural proteins and a DNA construct with a complex adjuvant. Methods: C57BL/6 and DBA/2J mice were immunized three times at 2-week intervals using different schemes. The viral antigens consisted of a mixture of NS3, NS5A, and NS5B proteins and/or recombinant DNA expressing NS3-NS5B polyprotein. As adjuvants, a complex adjuvant, a mixture of Polymuramil® and Pyrogenalum® (NOD1/NOD2 and TLR-4 agonists), or a CpG ODN adjuvant (TLR-9 agonist) were used. Results: The most efficient regimen was three subcutaneous administrations of the combined DNA, recombinant protein components, and a new complex adjuvant. This scheme elicited a robust immune response, characterized by high antibody titers, enhanced antigen-specific lymphocyte proliferation, and significant interferon-gamma (IFN-γ) secretion in both mouse lines. Furthermore, the complex adjuvant outperformed CpG ODN in stimulating both humoral and cellular immunity against the HCV antigens. The vaccine composition stimulated the formation of CD4+ memory T cells and decreased the relative frequences of suppressive Treg and MDSCs. Conclusions: The presented candidate vaccine induces a strong immune response to HCV proteins. The next step would be to validate the protective effect in cell culture and animal models. This would one the path to preclinical studies of this vaccine composition.
Open AccessImmunogenicity of a Candidate Hepatitis C Vaccine Based on Non-Structural DNA-Protein Sequences and a Novel Complex Adjuvant
Global elimination of hepatitis C virus (HCV) infection requires not only direct-acting antivirals (DAAs) but also the development of a highly effective prophylactic and/or therapeutic vaccine. Background/Objectives: Our aim was to optimize the composition of the candidate vaccine against HCV by combining recombinant non-structural proteins and a DNA construct with a complex adjuvant. Methods: C57BL/6 and DBA/2J mice were immunized three times at 2-week intervals using different schemes. The viral antigens consisted of a mixture of NS3, NS5A, and NS5B proteins and/or recombinant DNA expressing NS3-NS5B polyprotein. As adjuvants, a complex adjuvant, a mixture of Polymuramil® and Pyrogenalum® (NOD1/NOD2 and TLR-4 agonists), or a CpG ODN adjuvant (TLR-9 agonist) were used. Results: The most efficient regimen was three subcutaneous administrations of the combined DNA, recombinant protein components, and a new complex adjuvant. This scheme elicited a robust immune response, characterized by high antibody titers, enhanced antigen-specific lymphocyte proliferation, and significant interferon-gamma (IFN-γ) secretion in both mouse lines. Furthermore, the complex adjuvant outperformed CpG ODN in stimulating both humoral and cellular immunity against the HCV antigens. The vaccine composition stimulated the formation of CD4+ memory T cells and decreased the relative frequences of suppressive Treg and MDSCs. Conclusions: The presented candidate vaccine induces a strong immune response to HCV proteins. The next step would be to validate the protective effect in cell culture and animal models. This would one the path to preclinical studies of this vaccine composition.
- Open Access
- 10 December 2023
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 4,p. 37-48
The role of neutrophilic granulocytes and cationic proteins as biomarkers of the severity of the course of infectious and non-infectious animal diseases animal diseases
Innate immunity plays a decisive role in the primary reaction of the body to microbial agents. It is realized through the activation of cellular and humoral factors of nonspecific resistance – neutrophils, macrophages and antimicrobial and regulatory substances secreted by them, which, in turn, trigger a cascade of reactions involving lymphocytes. On the surface of the mucous membranes and in mucosal secretions, neutrophils realize their function not only through phagocytosis, but also through the release of DNA and bactericidal granules that form neutrophil extracellular traps. Violation of the functioning of these cells on the surface of the mucous membranes is considered as one of the factors of the formation of pathological microbial communities, leading to the development of dysbiosis and inflammation of various localization. The completed character of phagocytosis is provided by microbicidal systems of leukocytes: cationic proteins and myeloperoxidase. They have a special immunological significance and influence the course and outcome of the disease. Myeloperoxidase and cationic proteins are the main factors of bactericidal protection.
- 10 December 2023
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 4,p. 37-48
Open AccessThe role of neutrophilic granulocytes and cationic proteins as biomarkers of the severity of the course of infectious and non-infectious animal diseases animal diseases
Innate immunity plays a decisive role in the primary reaction of the body to microbial agents. It is realized through the activation of cellular and humoral factors of nonspecific resistance – neutrophils, macrophages and antimicrobial and regulatory substances secreted by them, which, in turn, trigger a cascade of reactions involving lymphocytes. On the surface of the mucous membranes and in mucosal secretions, neutrophils realize their function not only through phagocytosis, but also through the release of DNA and bactericidal granules that form neutrophil extracellular traps. Violation of the functioning of these cells on the surface of the mucous membranes is considered as one of the factors of the formation of pathological microbial communities, leading to the development of dysbiosis and inflammation of various localization. The completed character of phagocytosis is provided by microbicidal systems of leukocytes: cationic proteins and myeloperoxidase. They have a special immunological significance and influence the course and outcome of the disease. Myeloperoxidase and cationic proteins are the main factors of bactericidal protection.
- Open Access
- 9 October 2023
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 3,p. 35-50
Heuristic approaches to risk assessment and prognosis of sepsis in dogs
This study examines approaches to assessing the risk of death and predicting the development of sepsis in dogs. Sepsis remains one of the key clinical problems in medicine and veterinary medicine, due to its widespread prevalence throughout the world, leading to high mortality. Sepsis is based on the reaction of systemic inflammation of the body, which is realized in the presence of signs of SIRS, bacteremia and/or an infectious focus of various nature in combination with acute signs of organ dysfunction and/or evidence of microbial dissemination. Since sepsis develops only progressively, it is impossible for the animal to recover independently without providing it with timely and appropriate medical care. Today, one of the key issues remains improving approaches to assessing the risk of death and predicting the development of sepsis in dogs. An attempt to combine the pathogenicity factors of an infectious agent and the failure of the host’s defense mechanisms is reflected in the concepts of PIRO, SAPS and MODS, which evaluate the links in the etiopathogenesis of sepsis. Thus, heuristic approaches will allow us to come closer to the development of pathogenetically based methods for assessing the risk of death of animals and predicting the development of sepsis in dogs. These approaches are based on criteria for assessing PIRO indicators: predisposition (P), including breed, sex, age of the animal; infection (I) associated with the type of pathogen detected; systemic response of the body to infection R, characterized by the main clinical indicators - body temperature, heart rate, respiratory rate and the number of leukocytes in the blood; organ dysfunction (O) identified in one or more organs of the animal. An important role in the objective prognosis is given to the evaluation criteria on the SAPS scale, taking into account changes in indicators towards hyperinflammation (SIRS) or immunosuppression (MODS), which determine the stage of development of sepsis and the likelihood of the risk of death of the sick animal. On average, the predictive accuracy of quantifying disease severity systems is 70–85%. An algorithm for translating clinical and laboratory data into a SAPS scale of indicators (scores) that determines the severity of the disease in leptospirosis in dogs is proposed. It has been shown that on the SAPS scale for canine leptospirosis, a score of 29
- 9 October 2023
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 3,p. 35-50
Open AccessHeuristic approaches to risk assessment and prognosis of sepsis in dogs
This study examines approaches to assessing the risk of death and predicting the development of sepsis in dogs. Sepsis remains one of the key clinical problems in medicine and veterinary medicine, due to its widespread prevalence throughout the world, leading to high mortality. Sepsis is based on the reaction of systemic inflammation of the body, which is realized in the presence of signs of SIRS, bacteremia and/or an infectious focus of various nature in combination with acute signs of organ dysfunction and/or evidence of microbial dissemination. Since sepsis develops only progressively, it is impossible for the animal to recover independently without providing it with timely and appropriate medical care. Today, one of the key issues remains improving approaches to assessing the risk of death and predicting the development of sepsis in dogs. An attempt to combine the pathogenicity factors of an infectious agent and the failure of the host’s defense mechanisms is reflected in the concepts of PIRO, SAPS and MODS, which evaluate the links in the etiopathogenesis of sepsis. Thus, heuristic approaches will allow us to come closer to the development of pathogenetically based methods for assessing the risk of death of animals and predicting the development of sepsis in dogs. These approaches are based on criteria for assessing PIRO indicators: predisposition (P), including breed, sex, age of the animal; infection (I) associated with the type of pathogen detected; systemic response of the body to infection R, characterized by the main clinical indicators - body temperature, heart rate, respiratory rate and the number of leukocytes in the blood; organ dysfunction (O) identified in one or more organs of the animal. An important role in the objective prognosis is given to the evaluation criteria on the SAPS scale, taking into account changes in indicators towards hyperinflammation (SIRS) or immunosuppression (MODS), which determine the stage of development of sepsis and the likelihood of the risk of death of the sick animal. On average, the predictive accuracy of quantifying disease severity systems is 70–85%. An algorithm for translating clinical and laboratory data into a SAPS scale of indicators (scores) that determines the severity of the disease in leptospirosis in dogs is proposed. It has been shown that on the SAPS scale for canine leptospirosis, a score of 29
- Open Access
- 21 September 2023
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 68 (4) , 315-326
The adjuvant effect of polymuramil, a NOD1 and NOD2 agonist, differs when immunizing mice of different inbred lines with nonstructural hepatitis C virus (Flaviviridae: Hepacivirus)proteins and is synergistically enhanced in combination with pyrogenalum, a TLR4 agonist
Introduction. Hepatitis C is a liver disease with high chronicity, the cause of cirrhosis and hepatocarcinoma. The main obstacle to controlling hepatitis C is the lack of vaccines. The aim of the work was to compare the immunogenic activity of nonstructural recombinant proteins NS3, NS4 and NS5B of hepatitis C virus (HCV) as components of a subunit candidate vaccine and to analyze the adjuvant properties of two available commercial drugs, polymuramil and pyrogenalum. Materials and methods. BALB/c, DBA/2J and C57BL/6 mice were immunized with nonstructural proteins without adjuvants or with polymuramyl (NOD1 and NOD2 agonist) and pyrogenalum (TLR-4 agonist). The activity of antibodies was determined in ELISA, the cellular response by antigen-specific lymphocyte proliferation and by production of IFN- in vitro. Results. Recombinant proteins showed different immunogenicity. NS4 induced antibodies more efficiently than NS3 and NS5B. Significant differences were found in the immune response of three inbred lines mice: the level of IFN- in BALB/c and DBA/2J mice induced by NS5B protein was 30 times higher than in C57Bl/6 mice. In contrast, the induction of antibodies in BALB/c mice was lower than in C57Bl/6 and DBA/2J. Polymuramil did not increase the humoral response to NS5B and enhanced the cellular response only in C57BL/6 mice. The combined use of polymuramil with pyrogenalum significantly increased both the humoral and cellular response of mice to all recombinant HCV proteins. Conclusion. Different immunogenic properties and different functions of recombinant non-structural HCV proteins indicate the feasibility of their combined inclusion in subunit vaccines. It was established for the first time that immunization with HCV proteins with a complex adjuvant (polymuramyl + pyrogenalum) has a synergistic effect, significantly exceeding the effect of each of them separately.
- 21 September 2023
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 68 (4) , 315-326
Open AccessThe adjuvant effect of polymuramil, a NOD1 and NOD2 agonist, differs when immunizing mice of different inbred lines with nonstructural hepatitis C virus (Flaviviridae: Hepacivirus)proteins and is synergistically enhanced in combination with pyrogenalum, a TLR4 agonist
Introduction. Hepatitis C is a liver disease with high chronicity, the cause of cirrhosis and hepatocarcinoma. The main obstacle to controlling hepatitis C is the lack of vaccines. The aim of the work was to compare the immunogenic activity of nonstructural recombinant proteins NS3, NS4 and NS5B of hepatitis C virus (HCV) as components of a subunit candidate vaccine and to analyze the adjuvant properties of two available commercial drugs, polymuramil and pyrogenalum. Materials and methods. BALB/c, DBA/2J and C57BL/6 mice were immunized with nonstructural proteins without adjuvants or with polymuramyl (NOD1 and NOD2 agonist) and pyrogenalum (TLR-4 agonist). The activity of antibodies was determined in ELISA, the cellular response by antigen-specific lymphocyte proliferation and by production of IFN- in vitro. Results. Recombinant proteins showed different immunogenicity. NS4 induced antibodies more efficiently than NS3 and NS5B. Significant differences were found in the immune response of three inbred lines mice: the level of IFN- in BALB/c and DBA/2J mice induced by NS5B protein was 30 times higher than in C57Bl/6 mice. In contrast, the induction of antibodies in BALB/c mice was lower than in C57Bl/6 and DBA/2J. Polymuramil did not increase the humoral response to NS5B and enhanced the cellular response only in C57BL/6 mice. The combined use of polymuramil with pyrogenalum significantly increased both the humoral and cellular response of mice to all recombinant HCV proteins. Conclusion. Different immunogenic properties and different functions of recombinant non-structural HCV proteins indicate the feasibility of their combined inclusion in subunit vaccines. It was established for the first time that immunization with HCV proteins with a complex adjuvant (polymuramyl + pyrogenalum) has a synergistic effect, significantly exceeding the effect of each of them separately.
- Open Access
- 30 January 2023
- Published by Altai State Agrarian University in Bulletin of Altai State Agricultural University
- Vol. 219 (1) , 81-87
CATIONIC PROTEINS OF NEUTROPHILIC GRANULOCYTES IN THE PROGNOSIS OF PURULENT-SEPTIC POSTPARTUM COMPLICATIONS IN COWS
Инфекционный процесс при генерализации сопровождается полостной колонизацией патогенными гноеродными бактериями и запускает гнойно-септический патогенез в матке у коров при послеродовых осложнениях. Эпителиальные и стромальные клетки эндометрия воспринимают молекулярные паттерны, связанные с патогенами и повреждениями, через врожденные иммунные рецепторы, что приводит к высвобождению цитокинов и хемокинов. Эти медиаторы активируют и привлекают нейтрофилы и макрофаги. Клинические признаки внутриутробной инфекции варьируют в зависимости от вирулентности возбудителя и наличия факторов, предрасполагающих к заболеванию. Первая линия защиты организма от инфекции включает фагоцитоз при участии лизоцима, катионных белков и гидролитических ферментов. Катионные белки нейтрофилов являются модуляторами воспалительных реакций организма при сепсисе, который характеризуется присутствием микроорганизмов и их токсинов в крови. В представленных исследованиях выявлено достоверное повышение нейтрофильных гранулоцитов с различной степенью содержания в них гранул катионных белков, выраженной в виде среднего цитохимического коэффициента. При этом отмечено отсутствие маркерной динамики в клинико-гематологических показателях при гнойно-септических послеродовых осложнениях у коров, что определило прогностическую ценность теста на катионные белки. Генерализация бактериозов приводит в дальнейшем к снижению среднего цитохимического индекса катионных белков нейтрофилов, что свидетельствует о неблагоприятном прогнозе развития инфекционно-воспалительного процесса. Дальнейшее изучение структурных, антимикробных, цитотоксических и механистических свойств катионных белков гранулоцитов у коров расширяет знания, необходимые для разработки этих пептидов в качестве биомаркеров тяжести течения инфекционных заболеваний и новых терапевтических альтернатив антибиотикам.
- 30 January 2023
- Published by Altai State Agrarian University in Bulletin of Altai State Agricultural University
- Vol. 219 (1) , 81-87
Open AccessCATIONIC PROTEINS OF NEUTROPHILIC GRANULOCYTES IN THE PROGNOSIS OF PURULENT-SEPTIC POSTPARTUM COMPLICATIONS IN COWS
Инфекционный процесс при генерализации сопровождается полостной колонизацией патогенными гноеродными бактериями и запускает гнойно-септический патогенез в матке у коров при послеродовых осложнениях. Эпителиальные и стромальные клетки эндометрия воспринимают молекулярные паттерны, связанные с патогенами и повреждениями, через врожденные иммунные рецепторы, что приводит к высвобождению цитокинов и хемокинов. Эти медиаторы активируют и привлекают нейтрофилы и макрофаги. Клинические признаки внутриутробной инфекции варьируют в зависимости от вирулентности возбудителя и наличия факторов, предрасполагающих к заболеванию. Первая линия защиты организма от инфекции включает фагоцитоз при участии лизоцима, катионных белков и гидролитических ферментов. Катионные белки нейтрофилов являются модуляторами воспалительных реакций организма при сепсисе, который характеризуется присутствием микроорганизмов и их токсинов в крови. В представленных исследованиях выявлено достоверное повышение нейтрофильных гранулоцитов с различной степенью содержания в них гранул катионных белков, выраженной в виде среднего цитохимического коэффициента. При этом отмечено отсутствие маркерной динамики в клинико-гематологических показателях при гнойно-септических послеродовых осложнениях у коров, что определило прогностическую ценность теста на катионные белки. Генерализация бактериозов приводит в дальнейшем к снижению среднего цитохимического индекса катионных белков нейтрофилов, что свидетельствует о неблагоприятном прогнозе развития инфекционно-воспалительного процесса. Дальнейшее изучение структурных, антимикробных, цитотоксических и механистических свойств катионных белков гранулоцитов у коров расширяет знания, необходимые для разработки этих пептидов в качестве биомаркеров тяжести течения инфекционных заболеваний и новых терапевтических альтернатив антибиотикам.
- Open Access
- 7 December 2022
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 67 (6) , 516-526
Adjuvant effect of dispersed fullerene C60 on the immune response to constructs harboring amino acid and nucleotide sequences of hepatitis C virus nonstructural NS5B protein
Introduction. A vaccine against hepatitis C has not yet been developed. Recombinant proteins and plasmids encoding hepatitis C virus (HCV) proteins, the components of candidate vaccines, induce a weak immune response and require the use of adjuvants. The aim of the work was to study the adjuvant action of an aqueous solution of fullerene C60 during immunization of mice with HCV recombinant protein NS5B (rNS5B) that is an RNA-dependent RNA polymerase, or with NS5B-encoding pcNS5B plasmid. Materials and methods. An aqueous solution of dispersed fullerene (dnC60) was obtained by ultrafiltration. C57BL/6 mice were immunized with rNS5B subcutaneously, pcNS5B intramuscularly mixed with different doses of dnC60 three times, then the humoral and cellular response to HCV was evaluated. Results. Mice immunization with rNS5B in a mixture with dnC60 at doses of 250 g/mouse significantly induced humoral response: a dose-dependent increase in IgG1 antibody titers was 720 times higher than in the absence of fullerene. There was no increase in the cellular response to rNS5B when administered with dnC60. The humoral response to DNA immunization was weak in mice of all groups receiving pcNS5B. The cellular response was suppressed when the plasmid was injected in a mixture with dnC60. Conclusions. Dispersed fullerene dnC60 is a promising adjuvant for increasing the immunostimulating activity of weakly immunogenic proteins including surface and other HCV proteins, important for a protective response. Further research is needed to enhance the ability of dnC60 to boost the cellular immune response to the components of the candidate vaccine.
- 7 December 2022
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 67 (6) , 516-526
Open AccessAdjuvant effect of dispersed fullerene C60 on the immune response to constructs harboring amino acid and nucleotide sequences of hepatitis C virus nonstructural NS5B protein
Introduction. A vaccine against hepatitis C has not yet been developed. Recombinant proteins and plasmids encoding hepatitis C virus (HCV) proteins, the components of candidate vaccines, induce a weak immune response and require the use of adjuvants. The aim of the work was to study the adjuvant action of an aqueous solution of fullerene C60 during immunization of mice with HCV recombinant protein NS5B (rNS5B) that is an RNA-dependent RNA polymerase, or with NS5B-encoding pcNS5B plasmid. Materials and methods. An aqueous solution of dispersed fullerene (dnC60) was obtained by ultrafiltration. C57BL/6 mice were immunized with rNS5B subcutaneously, pcNS5B intramuscularly mixed with different doses of dnC60 three times, then the humoral and cellular response to HCV was evaluated. Results. Mice immunization with rNS5B in a mixture with dnC60 at doses of 250 g/mouse significantly induced humoral response: a dose-dependent increase in IgG1 antibody titers was 720 times higher than in the absence of fullerene. There was no increase in the cellular response to rNS5B when administered with dnC60. The humoral response to DNA immunization was weak in mice of all groups receiving pcNS5B. The cellular response was suppressed when the plasmid was injected in a mixture with dnC60. Conclusions. Dispersed fullerene dnC60 is a promising adjuvant for increasing the immunostimulating activity of weakly immunogenic proteins including surface and other HCV proteins, important for a protective response. Further research is needed to enhance the ability of dnC60 to boost the cellular immune response to the components of the candidate vaccine.
- Open Access
- 13 October 2022
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 3,p. 11-21
CRITERIA IN THE PROGNOSTIC OF GENERALIZATION OF BACTERIOSES IN DOGS WITH UTERINE INFLAMMATION
КРИТЕРИИ В ПРОГНОСТИКЕ ГЕНЕРАЛИЗАЦИИ БАКТЕРИОЗОВ У СОБАК С ВОСПАЛЕНИЕМ МАТКИ
- 13 October 2022
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 3,p. 11-21
Open AccessCRITERIA IN THE PROGNOSTIC OF GENERALIZATION OF BACTERIOSES IN DOGS WITH UTERINE INFLAMMATION
КРИТЕРИИ В ПРОГНОСТИКЕ ГЕНЕРАЛИЗАЦИИ БАКТЕРИОЗОВ У СОБАК С ВОСПАЛЕНИЕМ МАТКИ
- Open Access
- 26 June 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (13) , 6892
Difluoromethylornithine (DFMO), an Inhibitor of Polyamine Biosynthesis, and Antioxidant N-Acetylcysteine Potentiate Immune Response in Mice to the Recombinant Hepatitis C Virus NS5B Protein
Hepatitis C virus (HCV) is one of the main triggers of chronic liver disease. Despite tremendous progress in the HCV field, there is still no vaccine against this virus. Potential vaccines can be based on its recombinant proteins. To increase the humoral and, especially, cellular immune response to them, more effective adjuvants are needed. Here, we evaluated a panel of compounds as potential adjuvants using the HCV NS5B protein as an immunogen. These compounds included inhibitors of polyamine biosynthesis and urea cycle, the mTOR pathway, antioxidants, and cellular receptors. A pronounced stimulation of cell proliferation and interferon-γ (IFN-γ) secretion in response to concanavalin A was shown for antioxidant N-acetylcysteine (NAC), polyamine biosynthesis inhibitor 2-difluoromethylornithine (DFMO), and TLR9 agonist CpG ODN 1826 (CpG). Their usage during the immunization of mice with the recombinant NS5B protein significantly increased antibody titers, enhanced lymphocyte proliferation and IFN-γ production. NAC and CpG decreased relative Treg numbers; CpG increased the number of myeloid-derived suppressor cells (MDSCs), whereas neither NAC nor DFMO affected MDSC counts. NAC and DFMO suppressed NO and interleukin 10 (IL-10) production by splenocytes, while DFMO increased the levels of IL-12. This is the first evidence of immunomodulatory activity of NAC and DFMO during prophylactic immunization against infectious diseases.
- 26 June 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (13) , 6892
Open AccessDifluoromethylornithine (DFMO), an Inhibitor of Polyamine Biosynthesis, and Antioxidant N-Acetylcysteine Potentiate Immune Response in Mice to the Recombinant Hepatitis C Virus NS5B Protein
Hepatitis C virus (HCV) is one of the main triggers of chronic liver disease. Despite tremendous progress in the HCV field, there is still no vaccine against this virus. Potential vaccines can be based on its recombinant proteins. To increase the humoral and, especially, cellular immune response to them, more effective adjuvants are needed. Here, we evaluated a panel of compounds as potential adjuvants using the HCV NS5B protein as an immunogen. These compounds included inhibitors of polyamine biosynthesis and urea cycle, the mTOR pathway, antioxidants, and cellular receptors. A pronounced stimulation of cell proliferation and interferon-γ (IFN-γ) secretion in response to concanavalin A was shown for antioxidant N-acetylcysteine (NAC), polyamine biosynthesis inhibitor 2-difluoromethylornithine (DFMO), and TLR9 agonist CpG ODN 1826 (CpG). Their usage during the immunization of mice with the recombinant NS5B protein significantly increased antibody titers, enhanced lymphocyte proliferation and IFN-γ production. NAC and CpG decreased relative Treg numbers; CpG increased the number of myeloid-derived suppressor cells (MDSCs), whereas neither NAC nor DFMO affected MDSC counts. NAC and DFMO suppressed NO and interleukin 10 (IL-10) production by splenocytes, while DFMO increased the levels of IL-12. This is the first evidence of immunomodulatory activity of NAC and DFMO during prophylactic immunization against infectious diseases.